A case of thyroid hormone resistance syndrome due to previously undescribed mutation in the THRA gene

Abstract

Thyroid hormone resistance (THR) syndrome is characterized by decreased sensitivity of peripheral tissues to active forms of thyroid hormones. We present a clinical case of a patient, demonstrating symptoms of hypothyroidism while having subnormal FT4 and normal TSH and total T3 levels. Massive parallel sequencing allowed us to identify a previously undescribed heterozygous THRA c.1198C>G (p.Leu400Val) variant that arose de novo. The results of genetic testing corresponded well with the patient's phenotype that made it possible to verify the diagnosis of THR. Levothyroxine replacement therapy did not resulted in a significant clinical improvement; the use of supraphysiological doses led to refinement of the lipid profile but was accompanied by the appearance of some symptoms of thyrotoxicosis.

Related Papers

• → Combination Thyroid Hormone Replacement; Knowns and Unknowns(2019)20 cited
• → MEASUREMENT OF THE ACTIVE IODINE STORES AND DAILY HORMONAL OUTPUT OF THE INTACT HUMAN THYROID*(1957)14 cited
• → Physiological Effects of the Thyroid Hormones(1975)
• [Functional activity of the thyroid gland and distribution of its hormones in peripheral tissues under experimental liver disease].(1985)
• → Thyroid Hormone Replacement in Total Thyroidectomized Patients: Symptomatic and Metabolic Effects of Levothyroxine Monotherapy(2021)